WEIGAO GROUP (1066.HK)
- Previous Close
5.790 - Open
5.920 - Bid 5.830 x --
- Ask 5.860 x --
- Day's Range
5.770 - 6.000 - 52 Week Range
3.600 - 6.540 - Volume
5,458,841 - Avg. Volume
11,763,364 - Market Cap (intraday)
26.34B - Beta (5Y Monthly) 0.50
- PE Ratio (TTM)
12.19 - EPS (TTM)
0.480 - Earnings Date Mar 26, 2025
- Forward Dividend & Yield 0.26 (4.57%)
- Ex-Dividend Date Jun 2, 2025
- 1y Target Est
6.67
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The Medical Device Products segment includes safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions. The Orthopedic Products comprises spine, joint, trauma, sports medicine, orthopedic devices, bone repair material, spinal endoscope, PRP treatment consumables, and negative pressure drainage consumables. The Pharma Packaging Products consists prefilled drug delivery system, pharmaceutical packaging consumables, automatic drug delivery system, and pre-filled syringes. The Interventional Products segment offers tumor, vascular, and nursing interventions. The Blood Management Products segment comprises whole blood collection consumables and blood transfusion equipment. The Others segment consists of finance leases and factoring business. The company was founded in 1988 and is based in Weihai, the People's Republic of China.
www.weigaogroup.com12,719
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: 1066.HK
View MorePerformance Overview: 1066.HK
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1066.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1066.HK
View MoreValuation Measures
Market Cap
26.34B
Enterprise Value
21.91B
Trailing P/E
12.10
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.89
Price/Book (mrq)
1.03
Enterprise Value/Revenue
1.56
Enterprise Value/EBITDA
5.40
Financial Highlights
Profitability and Income Statement
Profit Margin
15.79%
Return on Assets (ttm)
4.15%
Return on Equity (ttm)
8.77%
Revenue (ttm)
13.09B
Net Income Avi to Common (ttm)
2.07B
Diluted EPS (ttm)
0.480
Balance Sheet and Cash Flow
Total Cash (mrq)
8.32B
Total Debt/Equity (mrq)
16.55%
Levered Free Cash Flow (ttm)
1.64B